The "Cui butler" beside me"
Release time:
2023-07-14
There is a busy figure active in Daye Peak Quality Control Department. As long as we need it, she will always appear in the first place. She is our quality supervisor Chen Cuihong running back and forth between the central control building and the production workshop.
Chen Cuihong entered daye peak work after graduating from university in 2009. He first worked in the analysis group of the quality control department and then was transferred to the office due to his outstanding work performance. In my impression, at that time, she was a shy "sister-in-law" with pimples on her face. She spoke softly, but she was resolute and unambiguous in doing things. She shuttled between the central control building and the production site every day. In particular, coal yard sampling was a "hard job" for our female employees who love beauty. At that time, it was an open-air coal yard. Before the coal shed was built, when the weather was bad, the wind blew "black snowflakes" and people became pandas after a short stay. At this time, she always helps us to carry coal, break coal, hammer coal, and finally divide the samples manually. At the end, the teeth are white. We are all worried that she will not be able to hold on. After all, she has just graduated with her youth dream. Who ever thought that she had been doing it for 14 years, from the ignorant teenager before to the "quality guard" who is now the only one ".
Although she usually mingles with us, she is selfless in her work and will never let go of mistakes. Sometimes the data input on the MS system is wrong. In our opinion, this is only a small mistake. It is good to change it, but she is very "serious". The first warning and the second direct assessment. We all think she is making a mountain out of a molehill, but she always says that the laboratory is the main functional department of the enterprise's product quality, and any product quality accident may bring great losses to the enterprise. She shuttles back and forth in various teams and groups every day, communicates with each other and solves practical problems in time when problems are found. Every year, she uses the time of kiln shutdown to train our inspectors in theoretical knowledge and practical operation to help us improve our skills to varying degrees. No matter whether it is big or small, no matter who encounters difficulties in life or work, Chen Cuihong will always patiently and enthusiastically help us solve various problems. Our quality control department has more female employees and more trivial things in life. Every time a child is uncomfortable or an old man has a headache or fever, she always asks whether she wants to rest or not (it is not convenient for the factory to go to town by car), just like our intimate housekeeper.
Enthusiasm is the soul of work, and responsibility is the attitude of work. Our "Cui butler" explains this sentence well. Although she often said that she thanked us for our company and helped her grow up along the way, we would like to say that we thank her for her help and let us better unite together. I hope that in the future work, under the leadership of "Cui butler", we can work together to do the work of the quality control department better and better. (Liu Su-ming)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31